Millennium Management’s Five Prime Therapeutics, Inc. FPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-25,616
| Closed | -$965K | – | 7470 |
|
|
2021
Q1 | $965K | Sell |
25,616
-339,404
| -93% | -$8.46M | ﹤0.01% | 4252 |
|
|
2020
Q4 | $6.21M | Buy |
365,020
+271,026
| +288% | +$3.4M | ﹤0.01% | 2232 |
|
|
2020
Q3 | $442 | Sell |
93,994
-259,063
| -73% | -$1.32M | ﹤0.01% | 3641 |
|
|
2020
Q2 | $2.15M | Buy |
353,057
+150,391
| +74% | +$619K | ﹤0.01% | 2472 |
|
|
2020
Q1 | $460K | Buy |
202,666
+35,953
| +22% | +$153K | ﹤0.01% | 2934 |
|
|
2019
Q4 | $765K | Sell |
166,713
-94,286
| -36% | -$373K | ﹤0.01% | 3131 |
|
|
2019
Q3 | $1.01M | Buy |
260,999
+145,251
| +125% | +$797K | ﹤0.01% | 2849 |
|
|
2019
Q2 | $698K | Buy |
+115,748
| New | +$1.11M | ﹤0.01% | 3026 |
|
|
2019
Q1 | – | Sell |
-198,171
| Closed | -$1.84M | – | 4470 |
|
|
2018
Q4 | $1.84M | Buy |
198,171
+55,450
| +39% | +$660K | ﹤0.01% | 2243 |
|
|
2018
Q3 | $1.99M | Sell |
142,721
-162,715
| -53% | -$2.42M | ﹤0.01% | 2447 |
|
|
2018
Q2 | $4.83M | Sell |
305,436
-52,311
| -15% | -$913K | 0.01% | 1839 |
|
|
2018
Q1 | $6.15M | Buy |
357,747
+94,035
| +36% | +$1.83M | 0.01% | 1672 |
|
|
2017
Q4 | $5.78M | Sell |
263,712
-89,151
| -25% | -$2.87M | 0.01% | 1668 |
|
|
2017
Q3 | $14.4M | Buy |
352,863
+139,564
| +65% | +$4.38M | 0.02% | 984 |
|
|
2017
Q2 | $6.42M | Sell |
213,299
-19,849
| -9% | -$620K | 0.01% | 1332 |
|
|
2017
Q1 | $8.43M | Buy |
+233,148
| New | +$10.3M | 0.02% | 1129 |
|
|
2016
Q3 | – | Sell |
-83,667
| Closed | -$3.46M | – | 3749 |
|
|
2016
Q2 | $3.46M | Buy |
+83,667
| New | +$3.64M | 0.01% | 1482 |
|
|
2016
Q1 | – | Sell |
-492,371
| Closed | -$20.4M | – | 3802 |
|
|
2015
Q4 | $20.4M | Sell |
492,371
-257,820
| -34% | -$8.64M | 0.04% | 564 |
|
|
2015
Q3 | $11.5M | Buy |
750,191
+276,622
| +58% | +$5.94M | 0.02% | 856 |
|
|
2015
Q2 | $11.8M | Sell |
473,569
-576,056
| -55% | -$12.8M | 0.02% | 884 |
|
|
2015
Q1 | $24M | Buy |
1,049,625
+703,853
| +204% | +$17.8M | 0.04% | 574 |
|
|
2014
Q4 | $9.34M | Buy |
345,772
+143,339
| +71% | +$2.47M | 0.02% | 1030 |
|
|
2014
Q3 | $2.38M | Buy |
202,433
+94,734
| +88% | +$1.2M | 0.01% | 1759 |
|
|
2014
Q2 | $1.68M | Sell |
107,699
-199,783
| -65% | -$2.87M | ﹤0.01% | 1897 |
|
|
2014
Q1 | $6.04M | Buy |
+307,482
| New | +$5.22M | 0.02% | 1107 |
|
Millennium Management's FPRX Position: Q2 2021 in Review
Millennium Management sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2021, closing a stake of 25,616 shares — an estimated $965K sold.
Millennium Management first reported a position in FPRX in Q1 2014 and held it in 25 quarters. The position peaked at $24M in Q1 2015. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.
- Millennium Management reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
- Millennium Management sold 25,616 Five Prime Therapeutics, Inc. shares in Q2 2021, an estimated $965K.
- Millennium Management first reported a position in Five Prime Therapeutics, Inc. in Q1 2014 and held it in 25 quarters.
- Millennium Management's Five Prime Therapeutics, Inc. position peaked at $24M in Q1 2015.
- 0 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2021.
Based on Millennium Management's 13F filing for Q2 2021, filed 16 Aug 2021.